Complete WAG: Treatment of opioid addiction with a mu opioid receptor antagonist is one of TTNP's current "feasability evaluations."
Approved mu opioid receptor antagonists are commonly known as naltexetone.
Vivitrol is a month long depot injection of naltexetone.
Could it be that Alkermes (Vivitrol) is trying to play in the 6 month implant market given Braeburn's going to be competing with them for the monthly injectable market?
It would be awesome to have the Pro Neura delivery systems providing both drugs...the more the merrier after all, its all royalties to Titan.
News 
Market Data 
Discover 
